Cardiopulmonary Exercise Test Interpretation Across the Lifespan in Congenital Heart Disease
Published: January 09, 2025
- Cardiopulmonary exercise testing (CPET) is a tool that qualitatively evaluates dynamic cardiovascular function, but many providers who care for these patients need more confidence in interpreting these findings. This document focuses on the key CPET findings in those with congenital HD across their lifespan.
- CPET can give robust prognostic information in congenital heart disease (HD), particularly in those with a Fontan circulation, Ebstein anomaly, and tetralogy of Fallot.
- CPET is essential for the comprehensive care of patients with congenital heart disease, offering valuable prognostic insights and assisting in clinical decision-making across various congenital heart conditions, thereby significantly improving patient management and outcomes.
Supporting Materials
Recommended Reading
- 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease
- 2024 ACC/AHA Clinical Performance and Quality Measures for Adults With Valvular and Structural Heart Disease
- Evaluation and Management of Chronic Heart Failure in Children and Adolescents With Congenital Heart Disease
- Neurodevelopmental Outcomes for Individuals With Congenital Heart Disease